Skila’s Simon Mason to Present Workshop at Marketing Excellence Europe 2009
Morris Plains, NJ, October 26, 2009 – On October 22, 2009, Skila’s Simon Mason, COO, presented a workshop entitled “Pan European Pharma Market Access & Marketing Innovation: Changing Market Access and Marketing Strategies By More Effectively Engaging Stakeholders, Payors and Influencers” at the Marketing Excellence Europe conference held in Berlin from October 22 – 23, 2009.
The workshop covered future trends and best practices in market access and marketing strategies for the life science industry. Participants learned:
How to become a knowledge agile organization
How Key Account Management based models are the future of pharma
Why a team based approach to selling is important
How to solve the challenge and create impact on the ground
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.
